| Literature DB >> 35641952 |
Anbrasi Edward1, Gibson B Kagaruki2,3,4,5, Frank Manase6, Lawrence J Appel7,8,9, Kunihiro Matsushita10.
Abstract
BACKGROUND: Inadequate adherence to hypertension (HT) clinical standards by healthcare providers is one of the major barriers for HT management. We examined the effectiveness of four short instructional training videos on HT management.Entities:
Keywords: Healthcare Provider Competency; Hypertension Management; Instructional Video Training; Tanzania
Mesh:
Year: 2022 PMID: 35641952 PMCID: PMC9153873 DOI: 10.1186/s12913-022-08064-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.908
Selected characteristics of Healthcare Providers and Health Facilities (Provider Interviews)
| Type of Provider | |
| 1(3.0) | |
| 21(63.6) | |
| 4(12.1) | |
| 7(21.2) | |
| Provider Gender | |
| 17(51.5) | |
| 16(48.5) | |
| Type of Facility | |
| 8(44.4) | |
| 10(55.6) | |
| Facility Management | |
| 11(61.1) | |
| 7(38.9) | |
Selected Characteristics of Patients Screened by Healthcare Providers (Patient Direct Observation)
| Patient Characteristics | Pre Intervention | Post Intervention a |
|---|---|---|
| Gender | ||
| 61(36.7) | 58(32.0) | |
| 105(63.3) | 123(68.0) | |
| Age | ||
| 64(38.6) | 65(36.5) | |
| 61(36.7) | 73(41.0) | |
| 41(24.7) | 40(22.5) | |
| 47.7(14.4) | 47.6(14.3) | |
| Patient BP screening point | ||
| 30(18.1) | 57(31.5)*** | |
| 96(57.8) | 114(63.0) | |
| 40(24.1) | 10(5.5) | |
a Different out-patients screened at pre- and post-intervention time periods
***p-value<0.001
Pre-Post Knowledge Differences by Healthcare Provider Cadre (Provider Interviews)
| Provider Knowledge Components | Assistant Medical Officer/Medical Officer | Assistant clinical officer/clinical officer | Total | |||
|---|---|---|---|---|---|---|
| Pre | Post | Pre | Post | Pre | Post | |
| Previous in-service training for HT | 3(27.3) | 11(100)*** | 7(31.8) | 22(100)*** | 10(30.3) | 33(100)*** |
| Type of training received | ||||||
| 2(66.7) | 10(90.9) | 2(28.6) | 20(90.9)** | 4(40.0) | 30(90.9)** | |
| 1(33.3) | 11(100)* | 5(71.4) | 20(90.9) | 6(60.0) | 31(93.9)* | |
| 1(33.3) | 11(100)* | 2(28.6) | 22(100)*** | 3(30.0) | 33(100)*** | |
| 1(33.3) | 10(90.9) | 2(28.6) | 19(86.4)** | 3(30.0) | 29(87.9)** | |
| 9(81.8) | 11(100) | 17(77.3) | 22(100)* | 26(78.8) | 33(100)** | |
| 10(90.9) | 11(100) | 19(86.4) | 21(95.5) | 29(87.9) | 32(97.0)* | |
| 9(81.8) | 10(90.9) | 14(63.6) | 22(100) | 23(69.7) | 32(97.0) | |
| 3(27.3) | 11(100)*** | 4(18.2) | 21(95.5)** | 7(21.2) | 32(97.0)*** | |
| 7(63.6) | 11(100)* | 20(90.9) | 22(100) | 27(81.8) | 33(100)* | |
| 11(100) | 10(90.9) | 22(100) | 22(100) | 33(100) | 32(97.0) | |
| 10(90.9) | 9(81.8) | 18(81.8) | 21(95.5) | 28(84.8) | 30(90.9) | |
| 11(100) | 10(90.9) | 21(95.5) | 22(100) | 32(97.0) | 32(97.0) | |
| 11(100) | 11(100) | 21(95.5) | 21(95.5) | 32(97.0) | 32(97.0) | |
| 7(63.6) | 10(90.9) | 10(45.5) | 18(81.8)* | 17(51.5) | 28(84.8)** | |
| 9(81.8) | 10(90.9) | 15(69.2) | 20(90.9) | 24(72.7) | 30(90.9) | |
| 8(72.7) | 10(90.9) | 15(68.2) | 21(95.5)* | 23(69.7) | 31(93.9)* | |
| 6(54.6) | 7(63.6) | 11(50.0) | 14(63.6) | 17(53.1) | 21(63.6) | |
| 8(72.7) | 7(63.6) | 18(81.8) | 19(86.4) | 26(78.8) | 26(78.8) | |
| 3(27.3) | 4(36.4) | 6(27.3) | 3(13.6) | 9(27.3) | 7(21.2) | |
| 11(100) | 10(90.9) | 20(90.9) | 21(95.5) | 31(96.9) | 31(96.9) | |
| Strategies to control HT: | 11(100) | 11(100) | 19(86.4) | 22(100) | 30(90.9) | 33(100) |
| Lifestyle changes to control HT; | 3(27.3) | 10(90.9)** | 9(40.9) | 22(100) | 12(36.4) | 32(97.0)*** |
| 8(72.7) | 10(90.9) | 17(77.3) | 20(90.9) | 25(75.8) | 30(90.9) | |
| 9(81.8) | 9(81.8) | 21(91.5) | 19(86.4) | 30(90.9) | 28(84.8) | |
| 10(90.9) | 6(54.6) | 17(77.3) | 21(95.5) | 27(84.4) | 27(84.4) | |
| 3(27.3) | 7(63.6) | 4(18.2) | 14(63.6)** | 7(21.2) | 21(63.6)** | |
| 11(100) | 11(100) | 22(100) | 22(100) | 33(100) | 33(100) | |
| 9(81.8) | 9(81.8) | 9(40.9) | 15(68.2) | 18(54.6) | 24(72.7) | |
| 3(27.3) | 5(45.5) | 13(59.1) | 13(59.1) | 16(48.5) | 18(54.6) | |
| 5(45.5) | 6(54.6) | 10(45.5) | 12(54.6) | 15(45.5) | 18(54.6) | |
| 1(9.1) | 5(45.5) | 8(36.4) | 8(36.4) | 9(27.3) | 13(39.4) | |
| 1(9.1) | 1(9.1) | 2(9.1) | 2(9.1) | 3(9.1) | 3(9.1) | |
*p-value<0.05, **p-value<0.01, ***p-value<0.001
Healthcare Provider Perspectives on Instructional Video Training (Post Intervention Provider Interview)
| Perspectives on Instructional Video Training | Assistant Medical Officer/Medical Officer | Assistant Clinical Officer/Clinical Officer | Total |
|---|---|---|---|
| n(%) | n(%) | n(%) | |
| Reviewed videos since workshop | 11(100) | 22(100) | 33(100) |
| If Yes, number of times (mean+/-SD) | 4.5(1.0) | 4.8(0.6) | 4.7(2.9) |
| Shared video link with other providers | 8(72.7) | 21(95.5) | 29(87.9) |
| Intent to include video content in clinical practice | 11(100) | 22(100) | 33(100) |
| Strongly Agree/Agree: | |||
| 10(90.9) | 22(100) | 32(97.0) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 10(90.9) | 21(95.5) | 31(93.9) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 22(100) | 33(100) | |
| 11(100) | 20(90.9) | 31(93.9) | |
| 9(81.8) | 22(100)* | 31(93.9) | |
| 8(72.7) | 22(100)* | 30(90.9) | |
| 11(100) | 21(95.5) | 32(97.0) | |
| 11(100) | 22(100) | 33(100) | |
*p-value<0.05, **p-value<0.01, ***p-value<0.001
Pre-Post Differences in Patient Preparation and Blood Pressure Screening (Patient Direct Observation)
| Screening Standards | Pts screened by | Patients Screened by AMO/MO | Patients screened by ACO/CO | |||
|---|---|---|---|---|---|---|
| Patient preparation prior to BP screening (automated/manual BP device) | Pre | Post | Pre | Post | Pre | Post |
| n(%) | n(%) | n(%) | n(%) | n(%) | n(%) | |
| 68(97.1) | 62(92.5) | 19(39.6) | 103(100)** | 55(62.5) | 20(95.2)** | |
| 62(88.6) | 60(89.6) | 20(41.7) | 92(89.3)*** | 61(69.3) | 20(95.2)* | |
| 42(60.0) | 53(79.1)* | 9(18.7) | 69(67.0)*** | 31(35.2) | 20(95.2)*** | |
| 61(87.1) | 66(98.5)* | 19(39.6) | 85(82.8)*** | 56(63.6) | 19(90.5)* | |
| 61(87.1) | 66(98.5)* | 21(43.7) | 85(82.5)*** | 53(60.2) | 20(95.2)** | |
| 64(91.4) | 67(100)* | 20(41.7) | 89(86.4)*** | 58(65.9) | 20(95.2)** | |
| 59(84.3) | 65(97.0)* | 20(41.7) | 88(85.4)*** | 54(61.4) | 20(95.2)** | |
| 55(78.6) | 59(88.1) | 20(61.7) | 90(87.4)*** | 56(63.6) | 19(90.5)* | |
| 41(58.6) | 57(85.1)** | 19(39.6) | 87(84.5)*** | 53(60.2) | 20(95.2)** | |
| 40(57.1) | 59(88.1)*** | 21(43.7) | 84(81.5)*** | 54(61.4) | 18(85.7)* | |
| 3±3.5 | 8.4± 1.0*** | 3.5± 4.1 | 7.6±2.4*** | 5.4± 3.8 | 8.4± 2.0*** | |
| 5(8.3) | 45(67.2)*** | 1(8.3) | 53(100)*** | 21(56.8) | 19(100)** | |
| 3(5.0) | 36(53.7)*** | 1(8.3) | 41(77.4)*** | 22(59.5) | 14(73.7)*** | |
| 9(90.0) | N/A | 10(27.8) | 48(96.0)*** | 26(51.0) | 1(50.0) | |
| 3(300) | N/A | 10(27.8) | 48(96.0)*** | 25(49.0) | 1(50.0) | |
| 5(50.0) | N/A | 1(2.8) | 27(54.0)*** | 0(0.0)_ | 1(50.0) | |
| N/A | N/A | 2(5.6) | 42(84.0) | 0(0.0) | 1(50.0) | |
| 20(28.6) | 34(51.5)** | 22(45.8) | 47(45.6) | 36(40.9) | 10(47.6) | |
| 70(100) | 67(100) | 20(41.7) | 103(100)*** | 60(69.2) | 20(95.2)* | |
| 0(0.0) | 20(29.9)*** | 2(4.2) | 99(96.1)*** | 17(19.3) | 20(95.2)*** | |
| 0(0.0) | 1(1.5) | 0(0.0) | 85(82.5)*** | 2(2.3) | 20(95.2)*** | |
| 50(71.4) | 45(67.2) | 0(0.0) | 53(51.5)*** | 7(7.9) | 9(42.9)*** | |
| 10(14.3) | 13(19.4) | 0(0.0) | 32(31.1)*** | 4(4.5) | 9(42.9)*** | |
*p-value<0.05, **p-value<0.01, ***p-value<0.001a Different out-patients recruited at post intervention phase. Ϯ Screening Quality Indicators. AMO Assistant Medical Officer MO Medical Officer ACO Assistant Clinical Officer CO Clinical Officer
Pre-Post Differences in Patient Management for Elevated BP (SBP≥140 and/or DBP ≥90) (Patient Direct Observation)
| Patient Management | Patients with elevated BP | |
|---|---|---|
| Pre ( | Post a ( | |
| Pt was prescribed lab tests | 46(68.7) | 75(79.8)* |
| Pt received information about the lab tests | 37(80.4) | 50(66.7) |
| 3(6.5) | 30(40.0)*** | |
| 2(4.4) | 4(5.3) | |
| 0(0.0) | 35(46.7)*** | |
| 14(30.4) | 37(49.3)* | |
| 6(13.0) | 22(29.3)* | |
| 31(67.4) | 42(56.0) | |
| Pt was prescribed antihypertensive medications | 29(43.3) | 41(43.6) |
| 1(3.5) | 3(7.3) | |
| 5(17.2) | 3(7.3) | |
| 10(34.5) | 12(29.3) | |
| 2(6.9) | 11(26.8) | |
| 15(51.7) | 27(65.9) | |
| 1(3.5) | 8(19.5) | |
| 2(6.9) | 2(4.9) | |
| Patient received counseling: | ||
| 18(62.1) | 38(92.7)** | |
| 12(41.4) | 23(56.1)** | |
| 23(79.3) | 39(95.1)* | |
| 28(96.6) | 41(100) | |
| 19(65.5) | 40(97.6)** | |
| 17(58.6) | 40(97.6)*** | |
| 23(79.3) | 39(95.1)* | |
| 20(69.0) | 39(95.1)** | |
| 16(55.2) | 38(92.7)*** | |
| 7(24.1) | 26(63.4)** | |
| 7(24.1) | 28(68.3)*** | |
| 23(79.3) | 39(95.1)* | |
| 4(13.8) | 20(48.8)*** | |
*p-value<0.05, **p-value<0.01, ***p-value<0.001a Different out-patients recruited at post intervention phase
Univariate and multivariate linear regression analysis of factors associated with hypertension screening quality index at pre and post intervention phase
| Patient Characteristics | Mean SQI | Unadjusted | Adjusted | ||
|---|---|---|---|---|---|
| Patient Sex (ref, Male) | 6.2(3.3) | ||||
| Female | 6.8(3.2) | 0.54(-0.18-1.3) | 0.141 | -0.12(-0.8-0.56) | 0.713 |
| Marital status (ref, Married) | 5.6(3.7) | ||||
| Single/divorced/widowed | 7.2(2.8) | 1.7(1.0-2.4) | <0.001 | 0.004(-0.8-0.8) | 0.993 |
| Patient Education (ref, none/primary) | 5.5(3.7) | ||||
| Secondary or more | 6.9(3.1) | 1.2(0.42-2.0) | 0.002 | -0.07(-0.9-0.8) | 0.875 |
| Patient age (ref, <50y) | 6.3(3.5) | ||||
| 50+y | 7.0(2.9) | 0.71(-0.01 -1.4) | 0.054 | 0.43(-0.23-1.10 | 0.200 |
| Main presenting symptom (ref, other) | 6.3(3.4) | ||||
| Weakness, dizziness, headache, chest pain, chest tightness, elevated BP | 7.0(3.1) | 0.70(-0.004 -1.4) | 0.051 | 0.5(-0.20-0.80) | 0.167 |
| Wealth Quintile (ref, lowest/low) | 7.1(3.0) | ||||
| Middle | 6.4(3.4) | -0.66(-1.6-0.29) | 0.174 | -0.40(-1.2-0.52) | 0.423 |
| High | 6.0(3.5) | -1.13(-2.0 to -0.24) | 0.013 | -0.78(-1.6-0.06) | 0.070 |
| Highest | 6.4(3.2) | -0.70(-1.73-0.32) | 0.179 | -0.25(-1.2-0.69) | 0.603 |
| Facility Ownership (ref, public) | 7.1(2.9) | ||||
| Private | 5.7(3.7) | -1.3(-2.0 to -0.62) | <0.001 | -3.2(-4.7 to -1.7) | <0.001 |
| Facility level (ref, dispensary) | 6.7(3.1) | ||||
| Health center | 6.5(3.4) | -0.22(-1.0-0.51) | 0.544 | ||
| Provider cadre (ref, nurse, assistant medical officer, clinical officer, assistant clinical officer) | 6.4(3.3) | ||||
| Medical officer (doctor) | 6.7(3.3) | 0.28(-042-1.0) | 0.429 | ||
| Provider Gender (ref, female) | 6.5(3.4) | ||||
| Male | 6.6(3.1) | 0.06(-0.63-0.75) | 0.865 | ||
| Providers’ work experience (ref, ≤2years) | 5.3(3.9) | ||||
| >2 years | 6.8(3.1) | 1.6(0.7-2.5) | <0.001 | -0.7(-2.0-0.58) | 0.279 |
| Provider work experience and facility ownership | N/A | 2.4(0.6-4.3) | 0.009 | 2.8(1.2-4.5) | 0.001 |
| Study Phase (ref, Pre intervention) | 5.1(3.8) | ||||
| Post Intervention | 7.9(1.9) | 2.8(2.2 -3.5) | <0.001 | 2.8(1.2-4.5) | <0.001 |
Wealth Quintile Asset Index: Electricity, as source of lighting, safe water source, cooking fuel: gas, electricity, kerosene, safe sanitation, motor cycle, bicycle, car, refrigerator, sewing machine, television, stove/gas cooker, radio, iron, cell phone, adequate flooring
Screening Quality Index Scores (SQI) 1.Patient informed that BP is being measured 2.Ensure patient rests 2-5m before measurement 3.Ensure patient back is supported 4.Ensure patient feet is supported 5.Ensure patient feet and legs are uncrossed 6.Place cuff on bare arm 7.Align middle of cuff at brachial artery 8.Place cuff at mid heart level 9.Ensure arm is rested 10. Pt does not speak, text, use cellphone during BP measurement
Pre-Post Differences of Patient Feedback of Clinical Visit related to HT (Patient Exit Interview)
| Pre Intervention Phase | Post Intervention Phase a | ||
|---|---|---|---|
| n(%) | n(%) | n(%) | |
| 148(90.2) | 181 (100) | <0.001 | |
| 131(88.5) | 166 (91.7) | 0.158 | |
| 56(34.8) | 75 (45.2) | 0.055 | |
| 47(28.7) | 57(31.5) | 0.481 | |
| 23(48.9) | 24(42.1) | 0.541 | |
| 3(12.5) | 6(18.2) | 0.520 | |
| 6(25.0) | 10(30.3) | 0.595 | |
| 1(4.2) | 0(0.0) | 0.129 | |
| 11(45.8) | 14(42.4) | 0.798 | |
| 4(16.7) | 2(6.1) | 0.218 | |
| 2(8.3) | 2(6.1) | 0.775 | |
| 88(53.7) | 43 (23.8) | <0.001 | |
| 17(10.4) | 121 (66.9) | <0.001 | |
| 58(35.4) | 101(55.8) | <0.001 | |
| 16(9.8) | 11 (6.1) | 0.297 | |
| 8(4.9) | 24 (13.3) | 0.004 | |
| 19(11.6) | 32 (17.7) | ||
| 51(76.1) | 69(73.4) | 0.697 | |
| 35(52.2) | 81(86.2) | <0.001 | |
| 41(61.2) | 75(79.8) | 0.010 | |
| 43(64.2) | 63(67.0) | 0.681 | |
| 44(65.7) | 64(68.1) | 0.748 | |
| 34(50.8) | 60(63.8) | 0.097 | |
| 20(29.9) | 47(50.0) | 0.011 | |
| 21(31.3) | 51(54.3) | 0.004 | |
| 24(51.1) | 55(94.8) | <0.001 | |
| 9(19.1) | 1 (1.7) | 0.002 | |
| 1(2.1) | 0 (0.0) | 0.264 | |
| 8(17.0) | 0 (0.0) | 0.001 | |
| 0(0.0) | 0 (0.0) | - | |
| 2(4.3) | 0 (0.0) | 0.113 | |
| 6(12.8) | 0 (0.0) | 0.006 | |
| 11(23.4) | 1 (1.7) | 0.001 | |
| 13(27.7) | 1 (1.7) | <0.001 | |
| 2(4.3) | 0 (0.0) | 0.127 | |
| 7(14.9) | 2 (3.5) | 0.025 | |
| Heard health messages on HT and consequences | 42(25.6) | 70 (38.7) | 0.010 |
| Received all medicines during visit | 110(67.1) | 98 (54.1) | <0.001 |
| Aware of dosage for all medicines | 120(85.1) | 122 (85.9) | 0.942 |
| Aware of timing for all medication | 111(79.3) | 120 (84.5) | 0.417 |
| Aware of duration for all medication | 113(81.3) | 123 (86.6) | 0.362 |
| Informed about side effects | 23(16.4) | 39 (27.7) | 0.032 |
| Cash | 56(38.9) | 69(52.3) | 0.004 |
| Health insurance | 39(27.1) | 41(31.1) | |
| No payment | 55(34.8) | 22(16.7) | |
| Average payment (Tanzania shillings) | 12,363 | 11,500 | 0.3535 |
*p-value<0.05, **p-value<0.01, ***p-value<0.001a Different patients examined at pre and post intervention